🇩🇪 SATRALIZUMAB in Germany

SATRALIZUMAB (SATRALIZUMAB) regulatory status in Germany.

Marketing authorisation

BfArM

  • Local brand name: Enspryng
  • Status: approved

SATRALIZUMAB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is SATRALIZUMAB approved in Germany?

Yes. BfArM has authorised it.

Who is the marketing authorisation holder for SATRALIZUMAB in Germany?

Marketing authorisation holder not available in our data.